JP2007513163A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513163A5
JP2007513163A5 JP2006542696A JP2006542696A JP2007513163A5 JP 2007513163 A5 JP2007513163 A5 JP 2007513163A5 JP 2006542696 A JP2006542696 A JP 2006542696A JP 2006542696 A JP2006542696 A JP 2006542696A JP 2007513163 A5 JP2007513163 A5 JP 2007513163A5
Authority
JP
Japan
Prior art keywords
composition
seq
activity
agonist
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006542696A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513163A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/040155 external-priority patent/WO2005060998A2/en
Publication of JP2007513163A publication Critical patent/JP2007513163A/ja
Publication of JP2007513163A5 publication Critical patent/JP2007513163A5/ja
Pending legal-status Critical Current

Links

JP2006542696A 2003-12-03 2004-12-01 サイトカイン活性を調節する方法；関連試薬 Pending JP2007513163A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52655803P 2003-12-03 2003-12-03
PCT/US2004/040155 WO2005060998A2 (en) 2003-12-03 2004-12-01 Methods of modulating cytokine activity; related reagents

Publications (2)

Publication Number Publication Date
JP2007513163A JP2007513163A (ja) 2007-05-24
JP2007513163A5 true JP2007513163A5 (https=) 2008-01-17

Family

ID=34710051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006542696A Pending JP2007513163A (ja) 2003-12-03 2004-12-01 サイトカイン活性を調節する方法；関連試薬

Country Status (6)

Country Link
US (2) US20050142108A1 (https=)
EP (1) EP1706421A2 (https=)
JP (1) JP2007513163A (https=)
CA (1) CA2549306A1 (https=)
MX (1) MXPA06006377A (https=)
WO (1) WO2005060998A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852588B2 (en) * 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies
CN107249630A (zh) * 2014-11-24 2017-10-13 国家健康与医学研究院 通过il‑20r的拮抗作用治疗慢性阻塞性肺疾病的急性加重
GB2543729A (en) * 2015-04-28 2017-05-03 Argen-X N V Antibodies to IL-24
WO2021086997A1 (en) * 2019-10-28 2021-05-06 LBL Biotechnology Inc. Treating tissue fibrosis and/or injury and-or organ failure with interleukin 24 or interleukin 20 antagonist

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985614A (en) * 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
EP2065396A1 (en) * 1996-08-30 2009-06-03 Human Genome Sciences, Inc. Interleukin-19
US20020072089A1 (en) * 1999-11-23 2002-06-13 Holtzman Douglas A. Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
WO2001055170A1 (en) * 2000-01-26 2001-08-02 Vanderbilt University Mob-5/hmob-5 as a cancer diagnostic marker
US20030100713A1 (en) * 2000-07-25 2003-05-29 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030023033A1 (en) * 2001-07-26 2003-01-30 Laure Dumoutier Novel class II cytokine receptors and uses thereof
US7157558B2 (en) * 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
US6902930B2 (en) * 2001-08-29 2005-06-07 Vanderbilt University Human Mob-5 (IL-24) receptors and uses thereof
CA2466229A1 (en) * 2001-11-06 2003-10-30 Eli Lilly And Company Use of il-19, il-22 and il-24 to treat hematopoietic disorders
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
US20040076606A1 (en) * 2002-09-14 2004-04-22 Ming-Shi Chang Methods of modulating inflammation by administration of interleukin-19 and inhibitors of IL-19 binding

Similar Documents

Publication Publication Date Title
DK2425259T3 (en) IMMUNOASSAY TO DETECT PROCALCITONIN
JP2016513644A5 (https=)
JP2005529587A5 (https=)
JP2015535820A5 (https=)
JP2009525758A5 (https=)
JP2012506551A5 (https=)
JP7586984B2 (ja) Ｉｌ－３３を定量するための方法
US11719697B2 (en) Immunoassay and antibodies for the detection of chromogranin A
CA2683911C (en) Immunoassay for quantification of an unstable antigen selected from bnp and probnp
JP2016540212A (ja) 多価多重特異性分子の生物学的活性を決定するためのｓｐｒベースの架橋アッセイ
US20180299399A1 (en) Electrochemical assay for a protein analyte
JP2007513163A5 (https=)
JP2018535403A (ja) 黒色腫の診断マーカーとしてのｇｄｆ−１５
WO2019235420A1 (ja) 複合体を検出する方法
WO2020158858A1 (ja) 生物学的試料中の遊離ａｉｍの免疫学的分析方法及び対象におけるｎａｓｈの検出方法
JP2021528411A5 (https=)
JP2022506108A (ja) グリコシル化ＡｐｏＪに特異的な抗体およびその使用
JP2024526081A (ja) 敗血症及び敗血症性ショックを予測する方法
WO2004027423A1 (ja) コラーゲンの測定方法
US20250138026A1 (en) Method for diagnosing collagen degradation associated disease
EA044802B1 (ru) Способы и композиции для количественного определения il-33
HK1229425B (en) Immunoassay for the detection of chromogranin a
HK1229884A1 (en) Biomarker for cardiac disorders